Shanghai Pharma mulls overseas acquisitions as it seeks to expand
This article was originally published in Scrip
Executive Summary
China's second-largest diversified pharma group Shanghai Pharmaceutical (SP) is planning to begin acquiring foreign companies as soon as the end of 2011 to bolster business beyond its traditional borders and expand its portfolio.